Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-019979
Filing Date
2021-08-16
Accepted
2021-08-16 10:44:58
Documents
64
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1011170
2 ex31-1.htm EX-31.1 17660
3 ex31-2.htm EX-31.2 17586
4 ex32-1.htm EX-32.1 5965
  Complete submission text file 0001493152-21-019979.txt   5902913

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE brtx-20210630.xsd EX-101.SCH 45662
6 XBRL CALCULATION FILE brtx-20210630_cal.xml EX-101.CAL 55047
7 XBRL DEFINITION FILE brtx-20210630_def.xml EX-101.DEF 209953
8 XBRL LABEL FILE brtx-20210630_lab.xml EX-101.LAB 401276
9 XBRL PRESENTATION FILE brtx-20210630_pre.xml EX-101.PRE 321652
10 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 977193
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 911835664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37603 | Film No.: 211175337
SIC: 8090 Services-Misc Health & Allied Services, NEC